XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -3.56%-185.56M | 38.40%-40.37M | 20.30%-36.71M | -41.47%-48.58M | -80.25%-59.89M | -172.32%-179.17M | -190.34%-65.54M | -151.03%-46.06M | -238.02%-34.34M | -125.84%-33.23M |
Net income from continuing operations | 49.75%-505.83M | 10.52%-178.84M | 70.58%-91.63M | -46.58%-171.36M | 83.09%-63.99M | -35.98%-1.01B | 21.56%-199.86M | -6,324.93%-311.43M | 63.98%-116.91M | -142.51%-378.46M |
Operating gains losses | -89.91%64.97M | 28.59%45.12M | -93.61%16.46M | -106.73%-3.33M | -97.77%6.73M | 6.06%644.1M | -83.53%35.09M | 1,581.68%257.38M | -83.05%49.51M | 152.68%302.12M |
Depreciation and amortization | 34.15%21.98M | -21.88%4.22M | 40.12%3.46M | 167.24%9.97M | -9.39%4.34M | 399.30%16.39M | 128.36%5.4M | 695.07%2.47M | 1,139.82%3.73M | 1,458.12%4.79M |
Deferred tax | 64.59%-3.89M | 99.98%-1.8K | -99.74%1.2K | -430.20%-2.17M | -249.69%-1.73M | -687,030.13%-10.99M | ---10.55M | --456.19K | ---408.35K | ---493.65K |
Other non cash items | 6,255.90%54.79M | 953.23%40.42M | 2,561.46%14.15M | -96.37%181.35K | -53.51%34.67K | -97.43%862.05K | -147.30%-4.74M | 102.42%531.69K | -78.32%4.99M | -99.67%74.58K |
Change In working capital | 19.26%7.22M | -9.73%8.18M | 217.33%7.26M | 111.09%10.96M | -850.15%-19.18M | 145.61%6.05M | 302.65%9.06M | -69.41%-6.18M | 4,866.96%5.19M | 59.90%-2.02M |
-Change in receivables | --547.46K | ---124.3K | --0 | --0 | --671.75K | --0 | --0 | --0 | --0 | --0 |
-Change in inventory | -103.71%-36.27M | 14.38%-15.25M | ---4.87M | ---2.24M | ---13.91M | ---17.81M | ---17.81M | --0 | --0 | --0 |
-Change in prepaid assets | 137.11%8.42M | 201.18%8.7M | 107.69%447.47K | 467.21%1.05M | 78.94%-1.78M | -828.43%-22.69M | ---8.6M | ---5.82M | --185.94K | ---8.46M |
-Change in payables and accrued expense | -24.42%34.98M | -59.27%14.43M | 4,497.09%11.1M | 125.60%11.17M | -128.09%-1.73M | 375.15%46.28M | 874.94%35.44M | 94.87%-252.43K | 201.36%4.95M | 351.32%6.15M |
-Change in other working capital | -274.51%-455.86K | 1,281.58%416.88K | 610.33%582.71K | 1,665.83%978.46K | -939.80%-2.43M | -40.77%261.22K | -93.62%30.17K | ---114.18K | --55.41K | --289.82K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -3.56%-185.56M | 38.40%-40.37M | 20.30%-36.71M | -41.47%-48.58M | -80.25%-59.89M | -172.32%-179.17M | -190.34%-65.54M | -151.03%-46.06M | -238.02%-34.34M | -125.84%-33.23M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 85.04%-16.15M | -342.24%-2.09M | 84.21%-1.58M | -51.39%-5.6M | 92.67%-6.87M | -128.87%-107.92M | 98.68%-473.55K | -1,772.07%-10.03M | -1,243.90%-3.7M | -795.78%-93.72M |
Net PPE purchase and sale | 86.27%-14.75M | -286.16%-694.22K | 84.21%-1.58M | -56.89%-5.6M | 92.67%-6.87M | -527.96%-107.42M | 97.07%-179.78K | -2,003.35%-10.03M | -12,079.76%-3.57M | -795.06%-93.64M |
Net intangibles purchase and sale | --0 | --0 | --0 | --0 | --0 | -20.05%-498.43K | -166.73%-293.77K | --0 | 47.25%-129.83K | ---74.83K |
Net business purchase and sale | ---1.4M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 85.04%-16.15M | -342.24%-2.09M | 84.21%-1.58M | -51.39%-5.6M | 92.67%-6.87M | -128.87%-107.92M | 98.68%-473.55K | -1,772.07%-10.03M | -1,243.90%-3.7M | -795.78%-93.72M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -84.16%56.76M | 961.38%49.25M | -93.67%12.45M | -128.49%-4.95M | 0 | 81.68%358.42M | -107.00%-5.72M | 1,237.34%196.77M | -77.05%17.36M | 495.37%150M |
Net issuance payments of debt | -61.99%56.76M | 526,685.87%49.25M | 5,633.33%12.45M | -975.18%-4.95M | --0 | 5,319.72%149.31M | -101.43%-9.35K | 55.81%-225K | -117.06%-460K | 2,731.42%150M |
Net common stock issuance | --0 | --0 | ---- | ---- | ---- | 352.78%191.39M | -364.89%-5.61M | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | --17.72M | ---97.79K | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -84.16%56.76M | 961.38%49.25M | -93.67%12.45M | -128.49%-4.95M | --0 | 81.68%358.42M | -107.00%-5.72M | 1,237.34%196.77M | -77.05%17.36M | 495.37%150M |
Net cash flow | ||||||||||
Beginning cash position | 84.53%155.7M | -98.26%3.96M | -65.64%29.81M | -17.21%88.94M | 84.53%155.7M | 199,964.22%84.38M | 272.16%227.43M | 32.88%86.75M | 174,695.33%107.43M | 199,964.22%84.38M |
Current changes in cash | -303.23%-144.95M | 109.46%6.78M | -118.37%-25.84M | -185.91%-59.13M | -389.57%-66.76M | -15.43%71.32M | -408.36%-71.74M | 3,473.23%140.68M | -131.71%-20.68M | 119,438.14%23.05M |
End cash Position | -93.10%10.75M | -93.10%10.75M | -98.26%3.96M | -65.64%29.81M | -17.21%88.94M | 84.53%155.7M | 84.53%155.7M | 272.16%227.43M | 32.88%86.75M | 174,695.33%107.43M |
Free cash flow | 30.23%-200.3M | 37.79%-41.07M | 31.73%-38.29M | -42.44%-54.19M | 47.41%-66.76M | -244.58%-287.1M | -129.04%-66.02M | -197.02%-56.09M | -264.58%-38.04M | -404.25%-126.95M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |